NCT01497496 Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Status COMPLETED Phase PHASE2
NCT01497392 Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers Status COMPLETED Phase PHASE1
NCT01496976 Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL Status COMPLETED Phase PHASE2
NCT01496534 Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01496118 Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01490749 Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer Status COMPLETED Phase PHASE1
NCT01487265 Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib Status COMPLETED Phase PHASE2
NCT01478347 A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults Status COMPLETED Phase PHASE3
NCT01472796 Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension Status UNKNOWN Phase PHASE4
NCT01469884 Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients Status COMPLETED Phase PHASE4
NCT01469572 Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases Status COMPLETED Phase PHASE1
NCT01467011 Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation Status COMPLETED Phase N/A
NCT01466387 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Status COMPLETED Phase PHASE3
NCT01463046 Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT01462214 Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01460940 A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT01458366 Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Status COMPLETED Phase PHASE1/PHASE2
NCT01454973 Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects Status COMPLETED Phase N/A
NCT01453595 BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) Status TERMINATED Phase PHASE1/PHASE2